wegovy
novo nordisk a/s - semaglutid - obesity; overweight - antiobesity preparations, excl. diætprodukter - wegovy is indicated as an adjunct to a reduced-calorie diet and increased physical activity for weight management, including weight loss and weight maintenance, in adults with an initial body mass index (bmi) of- ≥30 kg/m² (obesity), or- ≥27 kg/m² to.
tygacil
pfizer europe ma eeig - tigecycline - bacterial infections; skin diseases, bacterial; soft tissue infections - antibakterielle midler til systemisk brug, - tygacil is indicated in adults and in children from the age of eight years for the treatment of the following infections: , complicated skin and soft tissue infections (cssti), excluding diabetic foot infections, complicated intra-abdominal infections (ciai) , tygacil should be used only in situations where other alternative antibiotics are not suitable. det bør overvejes at officielle vejledning om hensigtsmæssig brug af antibakterielle midler.. hensigtsmæssig brug af antibakterielle midler..
mirapen 10 mg tabletter
teva pharma b.v. - ramipril - tabletter - 10 mg
mirapen 2,5 mg tabletter
teva pharma b.v. - ramipril - tabletter - 2,5 mg
mirapen 5 mg tabletter
teva pharma b.v. - ramipril - tabletter - 5 mg
glycel vandopløseligt koncentrat
excel industries (europe) nv - glyphosat - vandopløseligt koncentrat - 360 g/l glyphosat
lovastatin "stada" 20 mg tabletter
stada arzneimittel ag - lovastatin - tabletter - 20 mg
lovastatin "stada" 40 mg tabletter
stada arzneimittel ag - lovastatin - tabletter - 40 mg
clopidogrel/acetylsalicylic acid zentiva (previously duocover)
sanofi-aventis groupe - clopidogrel, acetylsalicylic acid - acute coronary syndrome; myocardial infarction - antitrombotiske midler - akut koronar syndromemyocardial myokardieinfarkt.